https://orcid.org/0000-0002-7259-4923
Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sariya Udayachalerm, Maranda G. Renouard, Thunyarat Anothaisintawee, Ammarin Thakkinstian, Sajesh K. Veettil & Nathorn Chaiyakunapruk. (2022) Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence. Journal of Medical Economics 25:1, pages 26-37.
Read now
Read now
Agam Vora, Alberta Di Pasquale, Shafi Kolhapure, Ashish Agrawal & Someya Agrawal. (2022) The need for vaccination in adults with chronic (noncommunicable) diseases in India – lessons from around the world. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Intissar Haddiya. (2020) Current Knowledge of Vaccinations in Chronic Kidney Disease Patients. International Journal of Nephrology and Renovascular Disease 13, pages 179-185.
Read now
Read now
Articles from other publishers (21)
Samantha Pérez-Cavazos, Eduardo Romo-Leija, José Iván Castillo-Bejarano & Abiel Homero Mascareñas-De los Santos. (2023) Shingles in an immunocompromised child: expect the unexpected. Pediatrics & Neonatology.
Crossref
Crossref
E. D. Lyutsova, V. P. Gadzhovska, M. D. Gospodinova & D. M. Radkova. (2023) Disseminated form of herpes zoster in an immunocompromised patient with oculocutaneous albinism. HIV Infection and Immunosuppressive Disorders 14:4, pages 93-97.
Crossref
Crossref
Selim Badur, Onur Ozudogru, Mansour Khalaf, Serdar Ozturk, Sarah Albreiki, Salah Al Awaidy & Adriana Guzman-Holst. (2022) Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature. Infectious Diseases and Therapy 12:1, pages 81-93.
Crossref
Crossref
Xiang Sun, Chenxi Dai, Kai Wang, Yuanbao Liu, Xinye Jin, Congyue Wang, Yi Yin, Zhongxing Ding, Zhenzhen Lu, Weiming Wang, Zhiguo Wang, Fenyang Tang, Kaifa Wang & Zhihang Peng. (2022) A Dynamic Compartmental Model to Explore the Optimal Strategy of Varicella Vaccination: An Epidemiological Study in Jiangsu Province, China. Tropical Medicine and Infectious Disease 8:1, pages 17.
Crossref
Crossref
Martin Sollie, Pernille Jepsen & Jens A Sørensen. (2022) Patient-reported quality of life in patients suffering from acute herpes zoster—a systematic review with meta-analysis. British Journal of Pain 16:4, pages 404-419.
Crossref
Crossref
Anna Majewska & Beata Mlynarczyk-Bonikowska. (2022) 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?. International Journal of Molecular Sciences 23:7, pages 3431.
Crossref
Crossref
Upender Malik, Shilpa Dutta Malik & Chhavi Srivastava. (2022) Trigeminal Herpes Zoster: A Brief Review. Journal of Skin and Stem Cell 8:4.
Crossref
Crossref
Catherina X. Pan, Michelle S. Lee & Vinod E. Nambudiri. (2022) Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 10, pages 251513552210845.
Crossref
Crossref
Jessica Vandenhaute, Elyonore Tsakeu, Pierre Chevalier, Manjiri Pawaskar, Goran Benčina & Jan Vertriest. (2021) Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infectious Diseases 21:1.
Crossref
Crossref
Nelli G. Prikhodchenko. (2021) Varicella-pox virus infection: features of the course, clinical manifestations, complications, and possibilities for prevention. Terapevticheskii arkhiv 93:11, pages 1401-1406.
Crossref
Crossref
Su Jeen Lee, Hun Kim, Kee-Jong Hong & Jae-Hwan Nam. (2021) Immune Responses to Varicella Zoster Virus and Effective Vaccines. Journal of Bacteriology and Virology 51:3, pages 103-111.
Crossref
Crossref
Brent A. Stanfield, Konstantin G. Kousoulas, Agustin Fernandez & Edward Gershburg. (2021) Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses 13:8, pages 1637.
Crossref
Crossref
Davide L. Vetrano, Federico Triolo, Stefania Maggi, Richard Malley, Thomas A. Jackson, Andrea Poscia, Roberto Bernabei, Luigi Ferrucci & Laura Fratiglioni. (2021) Fostering healthy aging: The interdependency of infections, immunity and frailty. Ageing Research Reviews 69, pages 101351.
Crossref
Crossref
James F Mbinta, Binh P Nguyen, Prosper Mandela A Awuni, Paul E Eme & Colin R Simpson. (2021) Postlicensure herpes zoster vaccine effectiveness: systematic review protocol. BMJ Open 11:2, pages e040964.
Crossref
Crossref
Shraddha Uprety, Sangeeta Paudel & Pratichya Thapa. (2021) Pattern of skin diseases in geriatric population: Our year-long experience from Nepal. Indian Dermatology Online Journal 12:6, pages 888.
Crossref
Crossref
Cynthia Bonville & Manika Suryadevara. 2021. Vaccines. Vaccines
383
396
.
Thomas J. Ellison, George C. Talbott & Daniel R. Henderson. (2020) VaxiPatch™, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017. Vaccine 38:43, pages 6839-6848.
Crossref
Crossref
Firza Alexander Gronthoud. 2020. Practical Clinical Microbiology and Infectious Diseases. Practical Clinical Microbiology and Infectious Diseases
357
361
.
Grisuna Singh, Sejin Song, Eunjoo Choi, Pyung-Bok Lee & Francis Sahngun Nahm. (2020)
Recombinant zoster vaccine (Shingrix
®
): a new option for the prevention of herpes zoster and postherpetic neuralgia
. The Korean Journal of Pain 33:3, pages 201-207.
Crossref
Crossref
Silvia Cocchio, Tolinda Gallo & Vincenzo Baldo. (2020) Herpes zoster: vaccination status and virtuous experiences. Minerva Medica 111:1.
Crossref
Crossref
Surbhi Khurana, ParulChawla Gupta, AshokKumar Singh & Jagat Ram. (2020) Herpes zoster ophthalmicus with ocular involvement in overtreated hyperthyroidism. Indian Journal of Ophthalmology 68:7, pages 1457.
Crossref
Crossref